Subscribe to our newsletter to receive the latest product updates and special offers

Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#11 / 100 Total
LBRT - Liberty Energy Inc - Stock Price Chart
TickerLBRT [NYSE, RUT]
CompanyLiberty Energy Inc
CountryUSA
IndustryOil & Gas Equipment & Services
Market Cap3.61BEPS (ttm)2.73
P/E7.92EPS this Y-21.73%
Forward P/E7.04EPS next Y23.69%
PEG-EPS past 5Y11.79%
P/S0.79EPS next 5Y-1.00%
P/B1.90EPS Q/Q-46.82%
Dividend1.42%Sales Q/Q-14.97%
Insider Own3.68%Inst Own99.49%
Insider Trans-7.98%Inst Trans-7.19%
Short Float10.20%EarningsApr 17/a
Analyst Recom2.06Target Price25.21
Avg Volume2.72M52W Range11.62 - 23.31
Liberty Energy, Inc. engages in the provision of hydraulic fracturing services to onshore oil and natural gas exploration for production companies in North America. The company was founded on December 21, 2016 and is headquartered in Denver, CO.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Wright Christopher AChairman of the Board and CEOMay 03 '24Sale21.6420,000432,8002,818,814May 03 07:50 PM
Wright Christopher AChairman of the Board and CEOMay 02 '24Sale21.3920,000427,8002,838,814May 03 07:50 PM
Stock MichaelChief Financial OfficerMay 01 '24Sale21.8320,000436,596825,209May 01 04:29 PM
Gusek RonPresidentApr 30 '24Sale22.7042,397962,5391,170,862Apr 30 04:36 PM
Gusek RonPresidentApr 29 '24Sale22.9950,0001,149,4701,213,259Apr 30 04:36 PM
TMUS - T-Mobile US Inc - Stock Price Chart
TickerTMUS [NASD, NDX, S&P 500]
CompanyT-Mobile US Inc
CountryUSA
IndustryTelecom Services
Market Cap192.89BEPS (ttm)7.35
P/E22.40EPS this Y30.93%
Forward P/E14.69EPS next Y23.49%
PEG0.88EPS past 5Y15.59%
P/S2.46EPS next 5Y25.48%
P/B3.12EPS Q/Q26.03%
Dividend1.61%Sales Q/Q-0.19%
Insider Own62.74%Inst Own38.84%
Insider Trans-2.24%Inst Trans-1.03%
Short Float5.31%EarningsApr 25/a
Analyst Recom1.52Target Price188.49
Avg Volume4.33M52W Range124.92 - 168.64
T-Mobile US, Inc. engages in the provision of wireless communications services under the T-Mobile and MetroPCS brands. It offers postpaid and prepaid wireless voice, messaging and data services, and wholesale wireless services. The company was founded in 1994 and is headquartered in Bellevue, WA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
DEUTSCHE TELEKOM AGDirectorMay 03 '24Sale164.63189,67031,225,521677,158,691May 03 07:50 PM
DEUTSCHE TELEKOM AGDirectorMay 02 '24Sale165.02189,67031,299,321677,348,361May 03 07:50 PM
DEUTSCHE TELEKOM AGDirectorMay 01 '24Sale165.67189,67031,423,286677,538,031May 03 07:50 PM
DEUTSCHE TELEKOM AGDirectorApr 30 '24Sale163.76189,67031,059,839677,727,701Apr 30 07:38 PM
DEUTSCHE TELEKOM AGDirectorApr 29 '24Sale164.15189,67031,134,333677,917,371Apr 30 07:38 PM
AMGN - AMGEN Inc. - Stock Price Chart
TickerAMGN [NASD, DJIA, NDX, S&P 500]
CompanyAMGEN Inc.
CountryUSA
IndustryDrug Manufacturers - General
Market Cap166.83BEPS (ttm)6.99
P/E44.51EPS this Y4.61%
Forward P/E15.05EPS next Y6.01%
PEG8.49EPS past 5Y-0.22%
P/S5.68EPS next 5Y5.25%
P/B33.25EPS Q/Q-103.99%
Dividend2.99%Sales Q/Q22.19%
Insider Own0.24%Inst Own78.10%
Insider Trans-1.09%Inst Trans-1.47%
Short Float1.89%EarningsMay 02/a
Analyst Recom2.13Target Price313.89
Avg Volume2.93M52W Range211.71 - 329.72
May-03-24Upgrade William Blair Mkt Perform → Outperform
May-03-24Upgrade Barclays Underweight → Equal Weight $230 → $300
Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. It operates through Human Therapeutics segment. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann, and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Grygiel Nancy A.SVP & CCOMay 03 '24Sale313.092,117662,8029,883May 03 07:48 PM
Grygiel Nancy A.SVP & CCODec 04 '23Sale273.032,096572,27610,874Dec 04 07:41 PM
Graham Jonathan PEVP, Gen. Counsel & Secy.Nov 08 '23Sale272.8110,0002,728,13628,078Nov 13 08:30 PM
AMGEN INC10% OwnerSep 19 '23Buy17.001,764,70529,999,98535,368,653Sep 19 07:52 PM
Gordon MurdoEVP, Global Commercial OpsAug 10 '23Sale262.439,5582,508,30644,308Aug 11 06:13 PM
DUOL - Duolingo Inc - Stock Price Chart
TickerDUOL [NASD, RUT]
CompanyDuolingo Inc
CountryUSA
IndustrySoftware - Application
Market Cap10.29BEPS (ttm)0.32
P/E743.03EPS this Y253.53%
Forward P/E102.83EPS next Y88.62%
PEG21.66EPS past 5Y-
P/S19.38EPS next 5Y34.30%
P/B15.57EPS Q/Q171.66%
Dividend-Sales Q/Q45.42%
Insider Own15.93%Inst Own77.13%
Insider Trans-6.91%Inst Trans-0.10%
Short Float4.98%EarningsMay 08/a
Analyst Recom2.12Target Price252.19
Avg Volume773.79K52W Range116.82 - 245.87
Duolingo, Inc. is a language-learning website and mobile application, which engages in the development of a free language learning website and crowd sourced text translation platform. It offers Duolingo for Schools, a free, web-based tool that aims to make it easier for teachers to use the Duolingo platform in a structured learning environment, and English Test, an online, on-demand assessment of English proficiency. The company was founded by Luis von Ahn and Severin Hacker in 2011 and is headquartered in Pittsburgh, PA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Skaruppa MatthewChief Financial OfficerMay 01 '24Option Exercise14.428,000115,36072,523May 03 07:38 PM
von Ahn LuisPresident & CEO, Co-FounderMay 01 '24Sale223.5112,0002,682,1390May 03 07:37 PM
Hacker SeverinChief Tech Officer, Co-FounderMay 01 '24Sale223.4710,0002,234,6530May 03 07:39 PM
Skaruppa MatthewChief Financial OfficerMay 01 '24Sale223.468,0001,787,70864,523May 03 07:38 PM
Glance NatalieChief Engineering OfficerApr 08 '24Sale215.351,500323,025124,505Apr 09 04:16 PM
RVMD - Revolution Medicines Inc - Stock Price Chart
TickerRVMD [NASD, RUT]
CompanyRevolution Medicines Inc
CountryUSA
IndustryBiotechnology
Market Cap6.85BEPS (ttm)-3.77
P/E-EPS this Y17.83%
Forward P/E-EPS next Y-7.55%
PEG-EPS past 5Y-36.05%
P/S591.86EPS next 5Y-
P/B3.62EPS Q/Q-80.53%
Dividend-Sales Q/Q-95.16%
Insider Own17.12%Inst Own76.44%
Insider Trans-0.50%Inst Trans8.22%
Short Float8.84%EarningsMay 08/a
Analyst Recom1.07Target Price41.62
Avg Volume1.50M52W Range15.44 - 39.60
May-01-24 04:05PM Revolution Medicines to Report Financial Results for First Quarter 2024 After Market Close on May 8, 2024 (GlobeNewswire)
Apr-09-24 03:34PM Revolution Medicines Announces Publication on the Discovery of and Translational Research for RMC-6236, an Investigational RAS(ON) Multi-Selective Tri-Complex Inhibitor Designed to Block Full Spectrum of Oncogenic RAS(ON) Proteins (GlobeNewswire)
Apr-08-24 11:36AM Revolution Medicines Announces Publications on the Discovery and Preclinical Profile of Representative of a New Class of RAS(ON) Multi-Selective Inhibitors Designed to Block Full Spectrum of Oncogenic RAS(ON) Proteins (GlobeNewswire)
Apr-04-24 04:05PM Revolution Medicines to Participate in Upcoming Investor Conferences (GlobeNewswire)
Mar-28-24 04:05PM Revolution Medicines to Deliver Multiple Presentations at the Upcoming American Association for Cancer Research Annual Meeting 2024 (GlobeNewswire)
Feb-26-24 05:20PM Revolution Medicines, Inc. (RVMD) Reports Q4 Loss, Lags Revenue Estimates (Zacks)
04:05PM Revolution Medicines Reports Fourth Quarter and Full Year 2023 Financial Results and Update on Corporate Progress (GlobeNewswire)
Feb-20-24 04:05PM Revolution Medicines to Report Financial Results for Fourth Quarter and Full Year 2023 After Market Close on February 26, 2024 (GlobeNewswire)
Feb-01-24 04:05PM Revolution Medicines to Participate in Upcoming Investor Conferences (GlobeNewswire)
Jan-17-24 09:55AM Wall Street Analysts See a 27.5% Upside in Revolution Medicines, Inc. (RVMD): Can the Stock Really Move This High? (Zacks)
Revolution Medicines, Inc. is a clinical-stage precision oncology company, which engages in developing novel targeted therapies. It engages in the discovery and development of cancer treatment by pioneering novel combination and monotherapy treatment regimens to maximize the depth and durability of clinical benefit and circumvent adaptive resistance mechanisms for patients which are dependent on the RAS and mTOR pathway. The company was founded by Mark A. Goldsmith, Kevan Shokat, Martin D. Burke, David L. Pompliano and Michael Fischbach in October 2014 and is headquartered in Redwood City, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Anders JackChief Financial OfficerMay 03 '24Option Exercise2.6810,00026,800111,959May 03 07:36 PM
Anders JackChief Financial OfficerMay 03 '24Sale40.0310,000400,260101,959May 03 07:36 PM
Patel SushilDirectorApr 10 '24Option Exercise16.802,15536,20417,855Apr 12 04:23 PM
GOLDSMITH MARK ASee RemarksApr 10 '24Sale35.3310,000353,34630,424Apr 12 08:08 PM
GOLDSMITH MARK ASee RemarksApr 10 '24Sale35.487,500266,122452,879Apr 12 08:08 PM
EXPO - Exponent Inc. - Stock Price Chart
TickerEXPO [NASD, RUT]
CompanyExponent Inc.
CountryUSA
IndustryEngineering & Construction
Market Cap4.78BEPS (ttm)1.97
P/E47.88EPS this Y-0.45%
Forward P/E46.19EPS next Y5.74%
PEG3.19EPS past 5Y7.81%
P/S8.83EPS next 5Y15.00%
P/B13.40EPS Q/Q4.70%
Dividend1.19%Sales Q/Q3.30%
Insider Own1.48%Inst Own93.47%
Insider Trans-2.34%Inst Trans-0.42%
Short Float2.87%EarningsApr 25/a
Analyst Recom2.33Target Price94.00
Avg Volume290.77K52W Range64.61 - 102.72
Exponent, Inc. is an engineering and scientific consulting company, which provides engineering, scientific, environmental, and health consulting services. It operates through the Engineering and Other Scientific, and Environmental and Health segments. The Engineering and Other Scientific segment includes technical consulting in different practices primarily in engineering. The Environmental and Health segment offers services in environmental, epidemiology, and health risk analysis. The company was founded by Bernard Ross in 1967 and is headquartered in Menlo Park, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
James Bradley AGroup Vice PresidentMay 03 '24Sale93.775,545519,9585,558May 03 07:34 PM
James Bradley AGroup Vice PresidentMay 02 '24Sale93.00131,20911,103May 03 07:34 PM
Guyer EricGroup Vice PresientApr 30 '24Sale92.581,650152,7621,846Apr 30 08:57 PM
Guyer EricGroup Vice PresientFeb 09 '24Sale78.493,367264,2890Feb 09 04:18 PM
SCHLENKER RICHARD L JREVP & Chief Financial OfficerFeb 06 '24Option Exercise17.705,64899,970288,990Feb 08 03:00 PM
ATEX - Anterix Inc - Stock Price Chart
TickerATEX [NASD, RUT]
CompanyAnterix Inc
CountryUSA
IndustryTelecom Services
Market Cap592.27MEPS (ttm)0.84
P/E38.28EPS this Y94.04%
Forward P/E-EPS next Y-3980.68%
PEG-EPS past 5Y12.62%
P/S167.31EPS next 5Y-
P/B3.44EPS Q/Q104.08%
Dividend-Sales Q/Q119.90%
Insider Own3.49%Inst Own87.94%
Insider Trans12.78%Inst Trans5.05%
Short Float5.85%EarningsFeb 14/a
Analyst Recom1.50Target Price70.25
Avg Volume120.65K52W Range27.20 - 40.45
Anterix, Inc. engages in commercializing spectrum assets to enable targeted utility and critical infrastructure customers to deploy private broadband networks, technologies and solutions. Its solutions include Private LTE and Active Ecosystem. The company was founded by Peter Joel Lasensky and Richard Edward Rohmann in 1997 and is headquartered in Woodland Park, NJ.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Gray TimothyChief Financial OfficerMay 03 '24Option Exercise20.0016,666333,320107,141May 03 07:34 PM
Gray TimothyChief Financial OfficerMay 03 '24Sale32.2616,666537,64590,475May 03 07:34 PM
Gray TimothyChief Financial OfficerMay 02 '24Option Exercise20.0016,667333,340107,142May 03 07:34 PM
Gray TimothyChief Financial OfficerMay 02 '24Sale31.9116,667531,84490,475May 03 07:34 PM
Gray TimothyChief Financial OfficerMay 01 '24Option Exercise20.0016,667333,340107,142May 03 07:34 PM
VRNA - Verona Pharma Plc ADR - Stock Price Chart
TickerVRNA [NASD]
CompanyVerona Pharma Plc ADR
CountryUnited Kingdom
IndustryBiotechnology
Market Cap1.22BEPS (ttm)-0.69
P/E-EPS this Y-192.59%
Forward P/E-EPS next Y74.05%
PEG-EPS past 5Y19.36%
P/S-EPS next 5Y-
P/B5.06EPS Q/Q-27.40%
Dividend-Sales Q/Q-100.00%
Insider Own22.62%Inst Own63.99%
Insider Trans0.70%Inst Trans43.43%
Short Float10.12%EarningsMay 09/b
Analyst Recom1.00Target Price34.29
Avg Volume448.20K52W Range11.83 - 23.81
Verona Pharma Plc engages in the development and commercialization of therapeutics for the treatment of respiratory diseases. It focuses on developing inhaled ensifentrine for the maintenance treatment of chronic obstructive pulmonary disease. The company was founded by Michael J. A. Walker and Clive P. Page on February 24, 2005 and is headquartered in London, the United Kingdom.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Rickard Kathleen A.Chief Medical OfficerMay 03 '24Sale1.9636,24871,0322,621,552May 03 07:21 PM
Rickard Kathleen A.Chief Medical OfficerFeb 05 '24Sale2.2236,24880,5032,731,624Feb 05 06:11 PM
Edwards MartinDirectorNov 20 '23Buy1.8433,73661,973144,800Nov 22 05:09 PM
EBSWORTH DAVID RDirectorNov 06 '23Buy1.98160,000316,080844,643Nov 08 04:15 PM
Rickard Kathleen A.Chief Medical OfficerNov 03 '23Sale1.9258,752112,8042,840,640Nov 03 08:11 PM
HOOD - Robinhood Markets Inc - Stock Price Chart
TickerHOOD [NASD]
CompanyRobinhood Markets Inc
CountryUSA
IndustryCapital Markets
Market Cap15.70BEPS (ttm)-0.60
P/E-EPS this Y148.59%
Forward P/E43.95EPS next Y37.79%
PEG-EPS past 5Y-48.35%
P/S8.31EPS next 5Y-
P/B2.34EPS Q/Q118.21%
Dividend-Sales Q/Q24.61%
Insider Own49.49%Inst Own38.57%
Insider Trans-0.84%Inst Trans4.24%
Short Float7.13%EarningsMay 08/a
Analyst Recom2.89Target Price19.20
Avg Volume15.79M52W Range7.91 - 20.55
Robinhood Markets, Inc is a financial services platform that pioneered commission-free stock trading with no account minimums and fractional share trading. The firm is focused on providing retail brokerage and offers trading in U.S. listed stocks and Exchange Traded Funds, related options, and cryptocurrency trading, as well as cash management, which includes debit cards services. The company was founded by Vladimir Tenev and Baiju Prafulkumar Bhatt in 2013 and is headquartered in Menlo Park, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Tenev VladimirChief Executive OfficerMay 02 '24Sale17.0425,049426,87532,584May 03 07:19 PM
Warnick JasonChief Financial OfficerMay 01 '24Sale16.725,00083,602997,407May 03 07:14 PM
Bhatt BaijuDirectorApr 23 '24Sale17.61154,1602,714,8350Apr 25 06:46 PM
Bhatt BaijuDirectorApr 18 '24Sale17.1616,667285,9940Apr 22 06:42 PM
Tenev VladimirChief Executive OfficerApr 04 '24Sale18.67250,0004,668,6750Apr 08 06:40 PM
HLVX - HilleVax Inc - Stock Price Chart
TickerHLVX [NASD, RUT]
CompanyHilleVax Inc
CountryUSA
IndustryBiotechnology
Market Cap676.69MEPS (ttm)-3.04
P/E-EPS this Y3.21%
Forward P/E-EPS next Y-16.48%
PEG-EPS past 5Y-241.80%
P/S-EPS next 5Y-
P/B2.44EPS Q/Q-38.12%
Dividend-Sales Q/Q-
Insider Own64.61%Inst Own28.92%
Insider Trans-0.46%Inst Trans-0.53%
Short Float2.83%EarningsMar 20/a
Analyst Recom1.00Target Price29.25
Avg Volume158.57K52W Range9.94 - 20.22
HilleVax, Inc. is a clinical-stage biopharmaceutical company, which focuses on developing and commercializing novel vaccines. Its pipeline includes Norovirus and HIL-214. The company was founded by Maurice Hilleman and Tadataka Yamada on March 25, 2020 and is headquartered in Boston, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Kohli AdityaDirectorMay 03 '24Sale14.1572310,233782,878May 03 07:12 PM
Kohli AdityaDirectorMay 02 '24Sale14.016,00084,081783,601May 03 07:12 PM
Kohli AdityaDirectorMay 01 '24Sale14.031752,456789,601May 03 07:12 PM
Kohli AdityaDirectorApr 05 '24Sale14.446,00086,640789,776Apr 05 05:48 PM
Frazier Life Sciences X, L.P.10% OwnerApr 04 '24Buy14.508,850128,3258,544,187Apr 08 04:22 PM
12345678910